Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUR.L Regulatory News (SUR)

  • There is currently no data for SUR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Sureserve PLC

28 Jun 2023 15:26

Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Sureserve PLC 28-Jun-2023 / 15:25 GMT/BST


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MI Chelverton UK Equity Growth Fund

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Sureserve Group plc

(ISIN: GB00BSKS1M86)

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

27 June 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary 10p

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

 

0

N/A

 

(2) Cash-settled derivatives:

 

N/A

-

N/A

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

-

N/A

 

 

 TOTAL:

0

0

N/A

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary 10p shares

Sale

 

4,500,000

1.24

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

28 June 2023

Contact name:

Maitland Administration Services Limited

Telephone number*:

01245 398950

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
Category Code:RET - Sureserve PLC
TIDM:MISL
LEI Code:549300P2JF82DYWEXW33
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:254127
EQS News ID:1668043
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
28th Jan 20213:07 pmRNSHolding(s) in Company
23rd Dec 20202:34 pmRNSBulletin Board Correction
23rd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 202012:13 pmRNSNotice of Preliminary Results
16th Nov 202011:15 amRNSNotification of Major Holdings
16th Nov 202011:13 amRNSGrant and vesting of awards
13th Nov 20209:12 amRNSExercise of Options and Total Voting Rights
3rd Nov 20204:58 pmRNSHolding(s) in Company
2nd Nov 202010:43 amRNSNotification of Major Holdings
14th Oct 202010:53 amRNSExercise of Options and Total Voting Rights
13th Oct 20201:07 pmRNSHolding(s) in Company
6th Oct 202012:07 pmRNSExercise of Options and Total Voting Rights
6th Oct 20207:00 amRNSPost year-end trading update
7th Sep 20209:47 amRNSExercise of Options and Total Voting Rights
4th Sep 20209:40 amRNSTransaction by Directors / PDMR
1st Sep 20203:25 pmRNSHolding(s) in Company
19th Aug 20207:00 amRNSTrading Update: Delivering a strong performance
13th Aug 20209:10 amRNSExercise of Options and Total Voting Rights
3rd Jul 20203:14 pmRNSExercise of Options and Total Voting Rights
16th Jun 20202:32 pmRNSExercise of Options and Total Voting Rights
8th Jun 20203:02 pmRNSExercise of options and admission to trading
27th May 20207:00 amRNSInterim Results
21st May 20207:00 amRNSExercise of options and admission to trading
7th May 20207:00 amRNSExercise of options and admission to trading
30th Mar 20207:00 amRNSCOVID-19 Update and Dividend Payment Confirmation
18th Mar 202010:46 amRNSResult of AGM
18th Mar 20207:00 amRNSAGM Statement
20th Feb 20207:00 amRNSPosting of Annual Report and Notice of AGM
20th Feb 20207:00 amRNSPosting of Annual Report and Notice of AGM
21st Jan 20207:00 amRNSPreliminary Results
25th Nov 20195:15 pmRNSDirector Dealing
23rd Oct 20197:00 amRNSNet debt position
4th Oct 20197:00 amRNSPost year end trading update and Board changes
25th Jun 20197:00 amRNSDirectorate change
25th Jun 20197:00 amRNSInterim Results for the six months ended 31 March
24th Jun 20192:41 pmRNSChange of Adviser
24th Jun 201911:29 amRNSDirectors' disclosures
21st May 201912:44 pmRNSDirector/PDMR Shareholding
21st May 20197:00 amRNSHolding(s) in Company
16th May 20192:30 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSChange of Registered Office
15th Apr 20197:00 amRNSExercise of options
19th Mar 20191:26 pmRNSDirector Disclosure
19th Mar 201911:08 amRNSResults of AGM
18th Mar 201912:14 pmRNSDirectorate Change
12th Mar 201911:38 amRNSHolding(s) in Company
7th Mar 20192:25 pmRNSHolding(s) in Company
21st Feb 20197:00 amRNSPosting of Annual Report and Notice of AGM
22nd Jan 20197:00 amRNSPreliminary Results
9th Jan 20194:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.